Antibodies that bind both IL-17A and IL-17F
US8609099B2 · kind B2 · utility
11Cited by
6References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 8, 2010 |
| Grant date | Dec 17, 2013 |
| Priority date | — |
| Expiry date | Jul 13, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/809
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to blocking, inhibiting, reduceing, antagonizing or neutralizing the activity of IL-17A and IL-17F. IL-17A and IL-17F are cytokines that are involved in inflammatory processes and human disease. The present invention includes antibodies that bind both IL-17A and IL-17F, hybridomas that produce the antibodies, and methods of using the same in inflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.